These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 28138150)

  • 1. Finding host targets for HIV therapy.
    Tsui CK; Gupta A; Bassik MC
    Nat Genet; 2017 Jan; 49(2):175-176. PubMed ID: 28138150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.
    Park RJ; Wang T; Koundakjian D; Hultquist JF; Lamothe-Molina P; Monel B; Schumann K; Yu H; Krupzcak KM; Garcia-Beltran W; Piechocka-Trocha A; Krogan NJ; Marson A; Sabatini DM; Lander ES; Hacohen N; Walker BD
    Nat Genet; 2017 Feb; 49(2):193-203. PubMed ID: 27992415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
    Kruize Z; Maurer I; Boeser-Nunnink BDM; Booiman T; Kootstra NA
    AIDS; 2020 Jul; 34(9):1303-1312. PubMed ID: 32287057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of preferential CD4+ T-cell targets for HIV infection in the cervix.
    Joag VR; McKinnon LR; Liu J; Kidane ST; Yudin MH; Nyanga B; Kimwaki S; Besel KE; Obila JO; Huibner S; Oyugi JO; Arthos J; Anzala O; Kimani J; Ostrowski MA; ; Kaul R
    Mucosal Immunol; 2016 Jan; 9(1):1-12. PubMed ID: 25872482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picking the Survivor! CRISPR Reveals HIV Dependency Factors.
    Schott K; König R
    Trends Microbiol; 2017 Apr; 25(4):243-245. PubMed ID: 28233621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
    Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
    J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.
    Nasreddine N; Borde C; Gozlan J; Bélec L; Maréchal V; Hocini H
    J Immunol; 2011 May; 186(10):5687-95. PubMed ID: 21478402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.
    Goffinet C; Michel N; Allespach I; Tervo HM; Hermann V; Kräusslich HG; Greene WC; Keppler OT
    Retrovirology; 2007 Jul; 4():53. PubMed ID: 17655755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.
    Matsuda K; Hattori S; Kariya R; Komizu Y; Kudo E; Goto H; Taura M; Ueoka R; Kimura S; Okada S
    Biochem Biophys Res Commun; 2015 Feb; 457(3):288-94. PubMed ID: 25576356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
    Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
    J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene.
    Pandit A; de Boer RJ
    Sci Rep; 2015 Dec; 5():18088. PubMed ID: 26674113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.
    Monteiro P; Gosselin A; Wacleche VS; El-Far M; Said EA; Kared H; Grandvaux N; Boulassel MR; Routy JP; Ancuta P
    J Immunol; 2011 Apr; 186(8):4618-30. PubMed ID: 21398606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation.
    Landi A; Vermeire J; Iannucci V; Vanderstraeten H; Naessens E; Bentahir M; Verhasselt B
    Retrovirology; 2014 Dec; 11():118. PubMed ID: 25496667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CD4 receptor downregulation and its downstream signaling molecules on HIV-1 latency.
    Kim KC; Kim HG; Roh TY; Park J; Jung KM; Lee JS; Choi SY; Kim SS; Choi BS
    Biochem Biophys Res Commun; 2011 Jan; 404(2):646-51. PubMed ID: 21146497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Ip S; Munier ML; Kaufmann DE; Suzuki K; Brereton C; Sasson SC; Seddiki N; Koelsch K; Landay A; Grey P; Finlayson R; Kaldor J; Rosenberg ES; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD
    J Virol; 2006 Oct; 80(20):10162-72. PubMed ID: 17005693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
    Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D
    PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.